The C-terminal PDZ-ligand motif of the neuronal glycine transporter GlyT2 is required for efficient synaptic localization

https://doi.org/10.1016/j.mcn.2007.07.011Get rights and content

Abstract

The neuronal glycine transporter 2 (GlyT2) belongs to the large SLC6 family of Na+/Cl-dependent neurotransmitter transporters. At its extreme C-terminus, GlyT2 carries a type III PDZ domain binding motif (PDZ-ligand motif), which interacts with the PDZ domain protein syntenin-1. Here, we investigated the physiological role of the GlyT2 PDZ-ligand motif by a loss-of-function approach. Inactivation of the PDZ-ligand motif did not impair the localization, glycosylation and transport function of recombinant GlyT2 expressed in HEK293T cells. However, in transfected hippocampal neurons, the synaptic localization of GlyT2 was significantly reduced upon PDZ-ligand motif inactivation. Co-localization of GlyT2 with marker proteins of excitatory and inhibitory synapses was decreased by down to 50% upon PDZ-ligand motif deletion as compared to the wild-type protein. These data indicate that the C-terminal PDZ-ligand motif of GlyT2 plays an important role in transporter trafficking to and/or stabilization at synaptic sites.

Introduction

Glycine is the major inhibitory neurotransmitter of interneurons in spinal cord and brain stem, where it activates strychnine-sensitive postsynaptic glycine receptors (Betz and Laube, 2006, Lynch, 2004). To allow for high-frequency synaptic transmission, glycine concentrations in the synaptic cleft have to be tightly regulated. This is accomplished by two high-affinity glycine transporters (GlyTs), GlyT1 and GlyT2 (Liu et al., 1992, Lopez-Corcuera et al., 1991, Smith et al., 1992). The GlyTs belong to the SLC6a family of Na+/Cl-dependent neurotransmitter transporters, which share a common topology with twelve transmembrane domains and intracellular N- and C-termini (Eulenburg et al., 2005, Gether et al., 2006). The transmembrane domains 3 and 4 are connected by a large extracellular loop that harbors multiple N-glycosylation sites (Martinez-Maza et al., 2001). Although GlyT1 and GlyT2 share overlapping expression domains in caudal regions of the CNS, they differ in their cellular distributions. GlyT1 is a predominantly glial transporter mainly expressed by astrocytes (Adams et al., 1995, Zafra et al., 1995a, Zafra et al., 1995b). In addition, it has been found in glycinergic amacrine cells of the retina (Pow and Hendrickson, 1999) and, more recently, in a subset of hippocampal neurons (Cubelos et al., 2005a). In contrast, GlyT2 is concentrated at glycinergic nerve terminals in close proximity to the presynaptic release sites (Mahendrasingam et al., 2003, Zafra et al., 1995a) and constitutes the only specific marker protein of glycinergic interneurons known presently (Poyatos et al., 1997).

The importance of GlyTs for inhibitory neurotransmission has been proven by the generation of GlyT-deficient mice (Gomeza et al., 2003a, Gomeza et al., 2003b). Their analysis disclosed that GlyT1 and GlyT2 have vital but complementary functions in the nervous system of young postnatal mice. GlyT1 is essential for the removal of glycine from the synaptic cleft and hence important for terminating glycinergic neurotransmission, whereas GlyT2 is required for the reuptake of glycine into the presynaptic terminal and its subsequent loading into synaptic vesicles by the vesicular inhibitory amino acid transporter (VIAAT). In addition to its function at inhibitory synapses, GlyT1 has been shown to be involved in the regulation of extracellular glycine concentrations at NMDA receptor containing excitatory synapses (Gabernet et al., 2005, Tsai et al., 2004, Yee et al., 2006).

Although the transport activities of both GlyTs are thought to be tightly controlled, GlyT2 appears to be subject to particular regulatory mechanisms (Eulenburg et al., 2005). Different lines of evidence indicate that the surface availability of GlyT2 determines neuronal glycine uptake activity. In synaptosomal preparations, only about 5–10% of the total GlyT2 protein are present in the plasma membrane, whereas its major fraction is localized intracellularly, most likely in vesicles (Geerlings et al., 2002). One protein involved in the regulation of GlyT2 plasma membrane insertion is syntaxin 1A, which has been found to indirectly interact with the N-terminal domain of GlyT2 (Geerlings et al., 2000). In transfected cells, coexpression of GlyT2 with syntaxin 1A results in a down-regulation of transport activity. However, in synaptosomal preparations inactivation of syntaxin 1A reduced GlyT2-mediated substrate uptake (Lopez-Corcuera et al., 2001), suggesting that syntaxin 1A is involved in the regulation of both incorporation into and retrieval from the plasma membrane. Phorbol ester treatment causes enhanced GlyT2 internalization, showing that protein kinase C (PKC) contributes to the regulation of GlyT2 (Gomeza et al., 1995). Although direct phosphorylation of the transporter by PKC appears to be unlikely, residues required for PKC-induced down-regulation of GlyT2 have been identified within intracellular loop 2 (Fornes et al., 2004).

The presynaptic localization of GlyT2 implies that specific targeting and anchoring proteins must exist. Consistent with this view, the putative membrane trafficking protein Ulip6, a member of the unc-33 like phosphoprotein/collapsin response mediator protein family, has been reported to interact with the long N-terminal domain of GlyT2 (Horiuchi et al., 2000, Horiuchi et al., 2005). In addition, the C-terminal intracellular tails of transporters of the SLC6a family are thought to contain motifs that are important for the trafficking and/or activity of these membrane proteins (Farhan et al., 2004). Besides residues that have been suggested to regulate protein exit from the endoplasmic reticulum, the extreme C-terminus of GlyT2 comprises a class III PDZ (postsynaptic density 95/disc large/zona occludens 1) domain binding motif (termed PDZ-ligand motif here) to which syntenin-1, a synaptically enriched protein harboring two PDZ domains, binds (Ohno et al., 2004). In different studies, PDZ domain containing proteins have been shown to play crucial roles in the trafficking and anchoring of membrane proteins at synaptic sites (Bezprozvanny and Maximov, 2001, Kim and Sheng, 2004).

Here, we inactivated the PDZ-ligand motif of GlyT2 by either truncation or addition of an alanine at its C-terminal end. The resulting mutant transporters were indistinguishable from wild-type GlyT2 in surface expression and uptake activity but, upon expression in neuronal cells, displayed significantly reduced synaptic localization. Thus, the PDZ-ligand motif of GlyT2 is required for its efficient recruitment to or stabilization at the nerve terminal.

Section snippets

Generation of GlyT2 expression constructs

To analyze possible functions of the GlyT2-PDZ-ligand motif, cDNAs encoding the GlyT2a and b splice variants (Ebihara et al., 2004) were amplified by PCR from mouse spinal cord and introduced into pcDNA3.1(+) for eukaryotic expression (GlyT2wt). Two strategies were used to disrupt PDZ-ligand motif function, which generally requires the three C-terminal amino acids for efficient binding (Bezprozvanny and Maximov, 2001, Bjerggaard et al., 2004). First, the three C-terminal amino acids of GlyT2

Discussion

In this study, we investigated possible functions of the PDZ-ligand motif of GlyT2 in the processing, surface delivery, trafficking and synaptic targeting of this membrane protein in both HEK293T cells and primary hippocampal neurons by a loss-of-function approach. PDZ-ligand motif inactivation had no effect on transporter expression, plasma membrane insertion and function in HEK293T cells. In primary hippocampal neurons, however, mutation of the PDZ-ligand motif resulted in a significant

Materials

The following antibodies were used for immunocytochemistry and/or Western blotting: polyclonal GlyT2-specific antibodies, raised against the C-terminal domain (Guinea pig, Chemicon Temecula, USA, 1:5000, used for staining of neuronal cultures) or the N-terminal domain (Gomeza et al., 2003b, 1:500–1:2000); anti-EGFP (mouse monoclonal, clone Jl-8; Clontech, Mountain View, USA); anti-VIAAT (rabbit polyclonal, kindly provided by Bruno Gasnier, 1:1000); anti-gephyrin (mouse, monoclonal; mab7,

Acknowledgments

We thank Maren Krause and Ina Bartnik for technical assistance, Dr. Astrid Scheschonka for comments on the manuscript and Maren Baier for secretarial assistance. This work was funded by the Max-Planck Gesellschaft, Deutsche Forschungsgemeinschaft (SFB269 and SPP1172) and Fonds der Chemischen Industrie. W.A. was supported by an International Max-Planck-Research School Fellowship.

References (57)

  • U. Gether et al.

    Neurotransmitter transporters: molecular function of important drug targets

    Trends Pharmacol. Sci.

    (2006)
  • J. Gomeza et al.

    Regulation by phorbol esters of the glycine transporter (GLYT1) in glioblastoma cells

    Biochim. Biophys. Acta

    (1995)
  • J. Gomeza et al.

    Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition

    Neuron

    (2003)
  • J. Gomeza et al.

    Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality

    Neuron

    (2003)
  • H. Hirbec et al.

    Syntenin is involved in the developmental regulation of neuronal membrane architecture

    Mol. Cell. Neurosci.

    (2005)
  • M. Horiuchi et al.

    Ulip6, a novel unc-33 and dihydropyrimidinase related protein highly expressed in developing rat brain

    FEBS Lett.

    (2000)
  • F. Jaskolski et al.

    Differential trafficking of GluR7 kainate receptor subunit splice variants

    J. Biol. Chem.

    (2005)
  • M. Kneussel et al.

    Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model

    Trends Neurosci.

    (2000)
  • Q.R. Liu et al.

    Cloning and expression of a glycine transporter from mouse brain

    FEBS Lett.

    (1992)
  • B. Lopez-Corcuera et al.

    Purification of the sodium- and chloride-coupled glycine transporter from central nervous system

    J. Biol. Chem.

    (1991)
  • S. Mahendrasingam et al.

    Two approaches to double post-embedding immunogold labeling of freeze-substituted tissue embedded in low temperature Lowicryl HM20 resin

    Brain Res. Brain Res. Protoc.

    (2003)
  • R. Martinez-Maza et al.

    The role of N-glycosylation in transport to the plasma membrane and sorting of the neuronal glycine transporter GLYT2

    J. Biol. Chem.

    (2001)
  • T.R. Muth et al.

    Identification of sorting determinants in the C-terminal cytoplasmic tails of the gamma-aminobutyric acid transporters GAT-2 and GAT-3

    J. Biol. Chem.

    (1998)
  • K. Ohno et al.

    The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1

    Mol. Cell. Neurosci.

    (2004)
  • I. Poyatos et al.

    The glycine transporter GLYT2 is a reliable marker for glycine-immunoreactive neurons

    Brain Res. Mol. Brain Res.

    (1997)
  • I. Poyatos et al.

    Polarized distribution of glycine transporter isoforms in epithelial and neuronal cells

    Mol. Cell. Neurosci.

    (2000)
  • M. Schroder et al.

    ER stress and the unfolded protein response

    Mutat. Res.

    (2005)
  • K.E. Smith et al.

    Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors

    Neuron

    (1992)
  • Cited by (0)

    1

    Current address: Department of Neurology, Children's Hospital Boston, Harvard Medical School, 300, Longwood Avenue, Boston, MA 02115, USA.

    View full text